Triple-drugs therapy of HSV-1 stromal keratitis

COMBINATION_PRODUCT2 trials

Sponsors

Shanghai BDgene Co., Ltd.

Conditions

Herpes Simplex Virus Type I Stromal Keratitis

Phase 1

A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis

Active, not recruitingNCT06474416

Shanghai BDgene Co., Ltd.Herpes Simplex Virus Type I Stromal Keratitis

Start: 2023-09-04End: 2026-03-13Target: 16Updated: 2025-05-18

Phase 2

A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis

RecruitingNCT06474442

Shanghai BDgene Co., Ltd.Herpes Simplex Virus Type I Stromal Keratitis

Start: 2025-04-28End: 2027-03-31Target: 40Updated: 2025-05-18